Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Ongoing monitoring should include assessment of weight trends, OSA symptoms, cardiovascular risk factors, and medication adherence at regular intervals, typically every 3-6 months after stabilization
This means it mimics the action of GLP-1 by binding to and activating GLP-1 receptors in the body
As ovulation becomes more regular, fertility can increase unexpectedly in some women, especially those with PCOS or insulin resistance
In the Phase 3 REDEFINE 1 trial, CagriSema produced a mean body weight reduction of approximately 22.7% from baseline at 68 weeks in adults with obesity (without type 2 diabetes)
US$ 24.00
US$ 24.88
US$ 20.18
US$ 24.16
US$ 20.49
US$ 27.58
